Back
Labcorp Holdings 10K Form
Sell
48
LH
Labcorp Holdings
Last Price:
238.58
Seasonality Move:
4.92%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-04-30 | 10Q | LH/Labcorp Holdings Quarterly |
2024-02-26 | 10K | LH/Labcorp Holdings Annual |
2023-10-30 | 10Q | LH/Labcorp Holdings Quarterly |
2023-08-04 | 10Q | LH/Labcorp Holdings Quarterly |
2023-05-04 | 10Q | LH/Labcorp Holdings Quarterly |
2023-02-28 | 10K | LH/Labcorp Holdings Annual |
Receive LH News And Ratings
See the #1 stock for the next 7 days that we like better than LH
LH Financial Statistics
Sales & Book Value
Annual Sales: | $12.16B |
---|---|
Cash Flow: | $161.5M |
Price / Cash Flow: | 24.24 |
Annual Sales: | $97.61 |
Price / Book: | 2.47 |
Profitability
EPS (TTM): | 5.15000 |
---|---|
Net Income (TTM): | $435.5M |
Gross Margin: | $3.36B |
Return on Equity: | 5.45% |
Return on Assets: | 2.55% |
Labcorp Holdings Earnings Forecast
Key Labcorp Holdings Financial Ratios
- The Gross Profit Margin over the past 35 years for LH is 27.67%.
- The Selling, General & Administrative Expenses for LH have been equal to 16.62% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 47.75% of Operating Income.
- The Net Earning history of LH is 3.44% of Total Revenues.
- Per Share Earnings over the last 36 years have been positive in 23 years.
Labcorp Holdings Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | LH |
CUSIP: | 50540R |
Website: | labcorp.com |
Debt
Debt-to-Equity Ratio: | 0.83 |
---|---|
Current Ratio: | 1.44 |
Quick Ratio: | 1.1 |
Price-to-Earnings
Trailing P/E Ratio: | 50.58 |
---|---|
Forward P/E Ratio: | 15.11 |
LH Technical Analysis vs Fundamental Analysis
Sell
48
Labcorp Holdings (LH)
is a Sell
Is Labcorp Holdings a Buy or a Sell?
-
Labcorp Holdings stock is rated a Sell
The current Labcorp Holdings [LH] share price is $241.29. The Score for LH is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.